首页> 外文OA文献 >Production of biologically active recombinant HIV-1 protease and intehrase for the purpose of screening medicianl plant extracts
【2h】

Production of biologically active recombinant HIV-1 protease and intehrase for the purpose of screening medicianl plant extracts

机译:生产具有生物活性的重组HIV-1蛋白酶和intehrase,用于筛选medicianl植物提取物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human immunodeficiency virus (HIV) and its gradual weakening of the immune system is an ever growing threat. Acquired immune deficiency syndrome (AIDS), the final stage of HIV, renders a person vulnerable to various opportunistic infections, which in the end lead to death. Apart from intensive vaccine studies, treatment research mainly focuses on preventing the individual HIV enzymes (reverse transcriptase, integrase and protease) from performing their functions. Entry inhibitors, however, block viral entry into the cell, while antisense drugs lock onto the viral genome to keep it from functioning. In this study production of active recombinant HIV-1 protease and integrase was attempted for future drug screening programs. HIV-1 protease was cloned into a pET28b(+) vector and expressed in ROSETTA(DE3)pLysS cells. The protein was purified using a nickel-affinity column utilizing the hexa-histidine tag encoded by the vector. Gel filtration chromatography was attempted after refolding of the protease, but protease yield seemed to decrease with the additional purification step. Partially purified protease was characterized with kinetic studies. Kinetic parameters of HIV-1 protease were determined to be Km = 592 μM, Vmax = 0.59 μM/min and kcat = 31 s-1. HIV-1 integrase, which was cloned into a pET15b vector, was expressed in E. coli BL21(DE3) cells. The coding sequence had been mutated to introduce the amino acid substitutions F185K and C280S, increasing solubility of the protein. The first step in purification of this protein was nickel-affinity chromatography, after which cation exchange chromatography was attempted. HIV-1 integrase concentration was low throughout experiments and no clear elution from the cation exchange column could be observed. A non-radioactive enzyme linked HIV-1 integrase assay failed to detect integrase activity. Modifications to future studies of the integrase are suggested in the chapter involved.
机译:人类免疫缺陷病毒(HIV)及其免疫系统的逐渐弱化是一个日益严重的威胁。获得性免疫缺陷综合症(艾滋病)是艾滋病毒的最后阶段,使一个人容易遭受各种机会性感染,最终导致死亡。除了深入的疫苗研究之外,治疗研究主要集中在防止个别HIV酶(逆转录酶,整合酶和蛋白酶)发挥其功能。但是,进入抑制剂会阻止病毒进入细胞,而反义药物会锁定病毒基因组以阻止其发挥功能。在这项研究中,尝试生产活性重组HIV-1蛋白酶和整合酶用于未来的药物筛选程序。将HIV-1蛋白酶克隆到pET28b(+)载体中,并在ROSETTA(DE3)pLysS细胞中表达。使用镍亲和柱,利用载体编码的六组氨酸标签纯化蛋白质。蛋白酶重新折叠后尝试进行凝胶过滤层析,但是蛋白酶的收率似乎随着额外的纯化步骤而降低。通过动力学研究表征了部分纯化的蛋白酶。 HIV-1蛋白酶的动力学参数确定为Km = 592μM,Vmax = 0.59μM/ min和kcat = 31 s-1。克隆到pET15b载体中的HIV-1整合酶在大肠杆菌BL21(DE3)细胞中表达。已对编码序列进行了突变,以引入氨基酸取代F185K和C280S,从而增加了蛋白质的溶解度。纯化该蛋白质的第一步是镍亲和色谱,然后尝试进行阳离子交换色谱。在整个实验中,HIV-1整合酶的浓度均较低,并且未观察到阳离子交换柱的清晰洗脱。非放射性酶联HIV-1整合酶测定法未能检测到整合酶活性。有关章节建议对整合酶的未来研究进行修改。

著录项

  • 作者

    Bosch Janine;

  • 作者单位
  • 年度 2009
  • 总页数
  • 原文格式 PDF
  • 正文语种 English
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号